Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR). (Q40859779)

From Wikidata

Jump to navigation Jump to search

scientific article published on 8 June 2015

Language	Label	Description	Also known as
English	Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).	scientific article published on 8 June 2015

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26053050%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR) (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26053050%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Darren M. Ashcroft

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26053050%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Catherine H Smith

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26053050%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26053050%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Jonathan N. Barker

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26053050%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Nick J Reynolds

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26053050%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Christopher Griffiths

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26053050%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Richard B Warren

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26053050%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

A David Burden

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26053050%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Mark Lunt

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26053050%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Kathleen McElhone

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26053050%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Anthony D Ormerod

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26053050%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Caroline M Owen

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26053050%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

language of work or name

0 references

publication date

8 June 2015

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26053050%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Journal of Investigative Dermatology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26053050%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

135

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26053050%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

2632-2640

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26053050%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26053050%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

https://scigraph.springernature.com/pub.10.1038/jid.2015.208

0 references

Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes

1 reference

https://pubmed.ncbi.nlm.nih.gov/26053050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register

1 reference

https://pubmed.ncbi.nlm.nih.gov/26053050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Effect of Different Remission Definitions on Identification of Predictors of Both Point and Sustained Remission in Rheumatoid Arthritis Treated with Anti-TNF Therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26053050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Appraisal of the MedDRA conceptual structure for describing and grouping adverse drug reactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/26053050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of inadequate adherence on response to subcutaneously administered anti-tumour necrosis factor drugs: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort

1 reference

https://pubmed.ncbi.nlm.nih.gov/26053050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical predictors of non-response to any tumor necrosis factor (TNF) blockers: a retrospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26053050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical relevance of immunogenicity of biologics in psoriasis: implications for treatment strategies

1 reference

https://pubmed.ncbi.nlm.nih.gov/26053050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The British Association of Dermatologists' Biologic Interventions Register (BADBIR): design, methodology and objectives.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26053050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Body mass index in patients with moderate-to-severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry

1 reference

https://pubmed.ncbi.nlm.nih.gov/26053050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

'Happy' drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE network.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26053050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of gender on response to rituximab in patients with rheumatoid arthritis: results from the Autoimmunity and Rituximab registry.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26053050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and women

1 reference

https://pubmed.ncbi.nlm.nih.gov/26053050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medication compliance and persistence: terminology and definitions

1 reference

https://pubmed.ncbi.nlm.nih.gov/26053050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26053050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26053050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heterogeneity of response to biologic treatment: perspective for psoriasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26053050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extent and clinical consequences of antibody formation against adalimumab in patients with plaque psoriasis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26053050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis. Evidence from the Psocare project.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26053050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological practice: a multicentre observational study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26053050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/26053050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of serious adverse events associated with biologic and nonbiologic psoriasis systemic therapy: patients ineligible vs eligible for randomized controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/26053050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26053050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of adalimumab drug survival in psoriasis differ by reason for discontinuation: long-term results from the Bio-CAPTURE registry

1 reference

https://pubmed.ncbi.nlm.nih.gov/26053050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug survival rates in patients with psoriasis after treatment with biologics

1 reference

https://pubmed.ncbi.nlm.nih.gov/26053050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris

1 reference

https://pubmed.ncbi.nlm.nih.gov/26053050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug survival rates of biologic treatments in patients with psoriasis vulgaris

1 reference

https://pubmed.ncbi.nlm.nih.gov/26053050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determinants of drug survival for etanercept in a long-term daily practice cohort of patients with psoriasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26053050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of body mass index on retention rates of anti-TNF-alfa drugs in daily practice for psoriasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26053050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug survival is not significantly different between biologics in patients with psoriasis vulgaris: a single-centre database analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26053050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/JID.2015.208

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26053050%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26053050%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40859779&oldid=1515062774"